Nano-X Imaging (NNOX) to Release Quarterly Earnings on Monday

Nano-X Imaging (NASDAQ:NNOX) is expected to announce its Q4 2025 results before the market opens on Monday, April 6th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $3.9940 million for the quarter. Parties can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Tuesday, April 7, 2026 at 12:30 PM ET.

Nano-X Imaging Price Performance

Shares of NNOX opened at $2.41 on Friday. Nano-X Imaging has a 1-year low of $2.11 and a 1-year high of $5.86. The firm has a market capitalization of $157.57 million, a PE ratio of -1.83 and a beta of 1.39. The company’s fifty day moving average price is $2.49 and its 200-day moving average price is $3.16.

Analysts Set New Price Targets

Several analysts have issued reports on the company. D. Boral Capital restated a “buy” rating and issued a $5.00 target price on shares of Nano-X Imaging in a report on Tuesday, March 3rd. Weiss Ratings reissued a “sell (d-)” rating on shares of Nano-X Imaging in a research report on Monday, December 29th. Finally, Cantor Fitzgerald raised shares of Nano-X Imaging to a “strong-buy” rating in a report on Wednesday, March 4th. Three research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Nano-X Imaging has an average rating of “Buy” and a consensus price target of $5.00.

Institutional Trading of Nano-X Imaging

Several institutional investors and hedge funds have recently bought and sold shares of NNOX. Aristides Capital LLC acquired a new stake in Nano-X Imaging in the 4th quarter valued at about $30,000. CIBC Bancorp USA Inc. purchased a new position in Nano-X Imaging in the third quarter worth approximately $40,000. BNP Paribas Financial Markets grew its holdings in Nano-X Imaging by 193.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 11,994 shares of the company’s stock worth $62,000 after acquiring an additional 7,910 shares in the last quarter. Russell Investments Group Ltd. increased its position in shares of Nano-X Imaging by 62.1% in the 3rd quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock valued at $51,000 after purchasing an additional 5,283 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Nano-X Imaging by 529.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 13,794 shares of the company’s stock valued at $71,000 after purchasing an additional 11,604 shares during the last quarter. 21.49% of the stock is currently owned by hedge funds and other institutional investors.

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.